Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Journal of Viral Hepatitis
|
March 27, 2001
Cell transformation induced by hepatitis C virus NS3 serine protease
R Zemel, S Gerechet, H Greif, et al.
Structure (London, England : 1993)
|
March 15, 1994
Crystal structure of a catalytic antibody Fab with esterase-like activity
B Golinelli-Pimpaneau, B Gigant, T Bizebard, et al.
Journal of Viral Hepatitis
|
January 14, 2012
Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity
L Bachmetov, M Gal-Tanamy, A Shapira, et al.
Transplantation Proceedings
|
September 18, 1997
Hepatitis GBV-C viremia in liver, heart, and bone marrow recipients
R Zemel, Z Ben-Ari, D Aravot, et al.
Gastroenterology
|
January 1, 1977
A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study
L B Seeff, H J Zimmerman, E C Wright, et al.
Lancet (London, England)
|
November 15, 1975
Efficacy of hepatitis B immune serum globulin after accidental exposure. Preliminary report of the Veterans Administration Cooperative Study
L B Seeff, E C Wright, J D Finkelstein, et al.
Annals of Internal Medicine
|
March 1, 1978
Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study
L B Seeff, E C Wright, H J Zimmerman, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Journal of Viral Hepatitis
|
March 27, 2001
Cell transformation induced by hepatitis C virus NS3 serine protease
R Zemel, S Gerechet, H Greif, et al.
Structure (London, England : 1993)
|
March 15, 1994
Crystal structure of a catalytic antibody Fab with esterase-like activity
B Golinelli-Pimpaneau, B Gigant, T Bizebard, et al.
Journal of Viral Hepatitis
|
January 14, 2012
Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity
L Bachmetov, M Gal-Tanamy, A Shapira, et al.
Transplantation Proceedings
|
September 18, 1997
Hepatitis GBV-C viremia in liver, heart, and bone marrow recipients
R Zemel, Z Ben-Ari, D Aravot, et al.
Gastroenterology
|
January 1, 1977
A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study
L B Seeff, H J Zimmerman, E C Wright, et al.
Lancet (London, England)
|
November 15, 1975
Efficacy of hepatitis B immune serum globulin after accidental exposure. Preliminary report of the Veterans Administration Cooperative Study
L B Seeff, E C Wright, J D Finkelstein, et al.
Annals of Internal Medicine
|
March 1, 1978
Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study
L B Seeff, E C Wright, H J Zimmerman, et al.
Page
of 4